400 related articles for article (PubMed ID: 12512386)
1. Targeting the molecular pathophysiology of gastrointestinal stromal tumors with imatinib. Mechanisms, successes, and challenges to rational drug development.
Demetri GD
Hematol Oncol Clin North Am; 2002 Oct; 16(5):1115-24. PubMed ID: 12512386
[TBL] [Abstract][Full Text] [Related]
2. Imatinib mesylate: in the treatment of gastrointestinal stromal tumours.
Croom KF; Perry CM
Drugs; 2003; 63(5):513-22; discussion 523-4. PubMed ID: 12600228
[TBL] [Abstract][Full Text] [Related]
3. Identification and treatment of chemoresistant inoperable or metastatic GIST: experience with the selective tyrosine kinase inhibitor imatinib mesylate (STI571).
Demetri GD
Eur J Cancer; 2002 Sep; 38 Suppl 5():S52-9. PubMed ID: 12528773
[TBL] [Abstract][Full Text] [Related]
4. Targeting c-kit mutations in solid tumors: scientific rationale and novel therapeutic options.
Demetri GD
Semin Oncol; 2001 Oct; 28(5 Suppl 17):19-26. PubMed ID: 11740803
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal stromal tumors: chemotherapy and imatinib.
Muler JH; Baker L; Zalupski MM
Curr Oncol Rep; 2002 Nov; 4(6):499-503. PubMed ID: 12354362
[TBL] [Abstract][Full Text] [Related]
6. The GIST of targeted cancer therapy: a tumor (gastrointestinal stromal tumor), a mutated gene (c-kit), and a molecular inhibitor (STI571).
DeMatteo RP
Ann Surg Oncol; 2002 Nov; 9(9):831-9. PubMed ID: 12417503
[TBL] [Abstract][Full Text] [Related]
7. Management of gastrointestinal stromal tumors in the era of tyrosine kinase inhibitors.
George S; Desai J
Curr Treat Options Oncol; 2002 Dec; 3(6):489-96. PubMed ID: 12392638
[TBL] [Abstract][Full Text] [Related]
8. Tyrosine kinase inhibitors in the treatment of unresectable or metastatic gastrointestinal stromal tumors.
Nishida T; Doi T; Naito Y
Expert Opin Pharmacother; 2014 Oct; 15(14):1979-89. PubMed ID: 24990162
[TBL] [Abstract][Full Text] [Related]
9. Imatinib mesylate acts in metastatic or unresectable gastrointestinal stromal tumor by targeting KIT receptors--a review.
Sawaki A; Yamao K
Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S44-9. PubMed ID: 15309514
[TBL] [Abstract][Full Text] [Related]
10. Combined surgical and molecular therapy: the gastrointestinal stromal tumor model.
Gold JS; Dematteo RP
Ann Surg; 2006 Aug; 244(2):176-84. PubMed ID: 16858179
[TBL] [Abstract][Full Text] [Related]
11. Treatment of inoperable gastrointestinal stromal tumor (GIST) with Imatinib (Glivec, Gleevec).
Joensuu H
Med Klin (Munich); 2002 Jan; 97 Suppl 1():28-30. PubMed ID: 11831069
[TBL] [Abstract][Full Text] [Related]
12. Molecular research directions in the management of gastrointestinal stromal tumors.
Tarn C; Godwin AK
Curr Treat Options Oncol; 2005 Nov; 6(6):473-86. PubMed ID: 16242052
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal stromal tumors: rationale for surgical adjuvant trials with imatinib.
Cormier JN; Patel SR; Pisters PW
Curr Oncol Rep; 2002 Nov; 4(6):504-9. PubMed ID: 12354363
[TBL] [Abstract][Full Text] [Related]
14. Response markers and the molecular mechanisms of action of Gleevec in gastrointestinal stromal tumors.
Frolov A; Chahwan S; Ochs M; Arnoletti JP; Pan ZZ; Favorova O; Fletcher J; von Mehren M; Eisenberg B; Godwin AK
Mol Cancer Ther; 2003 Aug; 2(8):699-709. PubMed ID: 12939459
[TBL] [Abstract][Full Text] [Related]
15. C-kit, GIST, and imatinib.
Siehl J; Thiel E
Recent Results Cancer Res; 2007; 176():145-51. PubMed ID: 17607922
[TBL] [Abstract][Full Text] [Related]
16. Management of malignant gastrointestinal stromal tumours.
Joensuu H; Fletcher C; Dimitrijevic S; Silberman S; Roberts P; Demetri G
Lancet Oncol; 2002 Nov; 3(11):655-64. PubMed ID: 12424067
[TBL] [Abstract][Full Text] [Related]
17. [Tyrosine kinase inhibitor as a targeted therapy for GIST tumors].
Joensuu H
Duodecim; 2002; 118(22):2305-12. PubMed ID: 12523107
[No Abstract] [Full Text] [Related]
18. Targeting mutant kinases in gastrointestinal stromal tumors: a paradigm for molecular therapy of other sarcomas.
Heinrich MC; Corless CL
Cancer Treat Res; 2004; 120():129-50. PubMed ID: 15217222
[No Abstract] [Full Text] [Related]
19. Gastrointestinal stromal tumors (GIST): a model for molecule-based diagnosis and treatment of solid tumors.
Kitamura Y; Hirota S; Nishida T
Cancer Sci; 2003 Apr; 94(4):315-20. PubMed ID: 12824897
[TBL] [Abstract][Full Text] [Related]
20. Phase II, open-label study of PTK787/ZK222584 for the treatment of metastatic gastrointestinal stromal tumors resistant to imatinib mesylate.
Joensuu H; De Braud F; Coco P; De Pas T; Putzu C; Spreafico C; Bono P; Bosselli S; Jalava T; Laurent D; Casali PG
Ann Oncol; 2008 Jan; 19(1):173-7. PubMed ID: 17698976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
